Medicare Part D

Legislative & Regulatory Position

ERISA and Part D Preemption

AMCP opposes attempts to erode the Employee Retirement Income Security Act (ERISA) and Medicare Part D preemption. AMCP believes that the certainty that comes with a single uniform federal standard ensures that plans subject to these laws are better able to provide access to needed medications regardless of where the patient lives or works.
Legislation & Regulation, Medicare Part D
Letters, Statements & Analysis

AMCP Summary of Medicare Part D Rebate Rule

On November 20, HHS released a Final Rule that amends the discount safe harbor regulation to eliminate protections for price concessions offered by pharmaceutical manufacturers to plan sponsors and pharmacy benefit managers (PBMs) under contract with plan sponsors starting January 1, 2022.
Medicare Part D
Resource

Implications for Managed Care Pharmacy from the 2021 and 2022 Medicare Advantage and Part D Proposed Rule

AMCP webinar that reviewed the provisions contained in the proposed Contract Year 2021 and 2022 Medicare Advantage and Part D rule that was released by the Centers for Medicare and Medicaid Services (CMS) on February 5, 2020.
Generic Drugs, Government/Legal Affairs, Medicare Part D, Medication Therapy Management (MTM), Quality Care, Star Ratings, Legislation & Regulation